News
Search EMA's news announcements
We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours.
Jascayd slowed loss of lung function in patients with idiopathic or progressive pulmonary fibrosis
Wegovy tablets offer an alternative to subcutaneous injections
Vijoice addresses an unmet medical need for patients with severe or life-threatening PIK3CA-related overgrowth spectrum (PROS) disorders
The European Medicines Agency's (EMA) office is closed from 18:00 on Friday 22 May until 08:30 on Tuesday 26 May

19 multinational clinical trials have been authorised in addition to the historical average; 40.5% of the total number of clinical trials recruit participants within 200 days

Risk for the general population currently considered very low by ECDC
The European Medicines Agency's (EMA) office is closed from 18:00 on Wednesday 13 May until 08:30 on Monday 18 May

Act to improve availability, production and supply of critical medicines in the European Union

PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use

International panel of high-level experts will support EMA’s efforts to strengthen trust in vaccines